Steward Financial Group’s ResMed RMD Stock Holding History

Steward Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	1055
2022 Q2	$0	Buy	+4	New	+$852	﹤0.01%	1308

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Steward Financial Group's RMD Position: Q3 2022 in Review

Steward Financial Group sold out of ResMed (RMD) in Q3 2022, closing a stake of 4 shares.

Steward Financial Group first reported a position in RMD in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Steward Financial Group reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
Steward Financial Group sold 4 ResMed shares in Q3 2022.
Steward Financial Group first reported a position in ResMed in Q2 2022 and held it in 1 quarter.
Steward Financial Group's ResMed position peaked at $0 in Q2 2022.
667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Steward Financial Group's 13F filing for Q3 2022, filed 7 Nov 2022.